- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne - - Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 ...

The right treatment for the right patient is key to treating acne safely. Acne is a chronic disease of the pilosebaceous follicle that causes polymorph cutaneous lesions, among them comedones ...

The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol. Bartlett KB, Davis SA, Feldman SR. Tolerability of topical antimicrobials in ...

Acne vulgaris (AV) is considered an inflammatory disorder of pilosebaceous follicle. Current paradigm presumes the higher the triglyceride level, the greater probability of acne vulgaris (AV) ...

Evaluation of patients with acne should be made at intervals of 3 to 12 weeks, with more frequent consultations in the initial phase of the treatment. A topical maintenance therapy should be the ...

It also can't stop new breakouts from happening. So if facial steams are your main acne treatment, you'll always be playing catch up. Steaming has no effect on inflamed pimples and larger blemishes ...

said the clinical trial will help to generate valuable data on the disease and its treatment. “The translational study will explore the role of skin bacteria and biological responses in acne ...

based on new research since the previous guideline was published, include the key change that opioid agonist treatment with buprenorphine–naloxone is no longer the sole first-line treatment and ...

This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne -- Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 study ...

While facial acne may be the most common type of acne, pimples can pop up anywhere — including your chest, back and even your butt. Yes, you read that right. Butt acne (also called buttne ...